Arshia Rangchi
Papers
2
Total Citations
11
H-Index
2
About
Arshia Rangchi is a rising urologic surgeon-investigator whose work is redefining surgical approaches to benign prostatic hyperplasia (BPH) and bladder cancer. Her research centers on minimally invasive techniques, particularly comparing the efficacy and safety of en-bloc holmium laser enucleation of the prostate (HoLEP) versus robot-assisted simple prostatectomy (RASP) for medication-refractory BPH. In a landmark 2024 propensity-matched analysis (8 citations), she demonstrated that both procedures offer excellent outcomes, but HoLEP provides superior recovery profiles—a finding that helps guide surgical decision-making. Rangchi has also made significant contributions to the debate on radical cystectomy, publishing a decade-long, single-surgeon experience (2025, 3 citations) comparing open versus robotic approaches with intracorporeal neobladder reconstruction. Her work shows that robot-assisted surgery can match open techniques in oncological control while reducing perioperative morbidity. With a focus on evidence-based comparisons that directly impact patient quality of life, Rangchi is helping to establish new standards for urologic care. Her research is particularly valuable for trainees and clinicians seeking clarity on the trade-offs between emerging robotic platforms and established laser technologies.
Research Focus
Key Achievements
Top Papers
- 1
- 2